A novel intraperitoneal cefepime regime based on pharmacokinetic modeling to treat CAPD peritonitis

Perit Dial Int. 2010 Nov-Dec;30(6):660-1. doi: 10.3747/pdi.2009.00242.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Absorption
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / blood
  • Anti-Bacterial Agents / pharmacokinetics
  • Cefepime
  • Cephalosporins / administration & dosage*
  • Cephalosporins / blood
  • Cephalosporins / pharmacokinetics
  • Computer Simulation
  • Female
  • Follow-Up Studies
  • Humans
  • Infusions, Parenteral
  • Male
  • Middle Aged
  • Models, Chemical
  • Peritoneal Dialysis, Continuous Ambulatory / adverse effects*
  • Peritonitis / drug therapy*
  • Peritonitis / etiology
  • Time Factors

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Cefepime